Stock Comparison

VRAX vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricVRAXVirax Biolabs Group LimitedAAPLApple Inc.
Market Cap$2.33M$3.8T
Current Price$0.31$258.21
P/E Ratio-0.1634.61
Revenue Growth 1Y-96%6.4%
Net Margin-957.4%26.9%
ROE-114.4%171.4%
ROIC-273.2%70.6%
Debt/Equity0.071.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

VRAX vs AAPL: Key Questions Answered

Which stock is growing the fastest: VRAX or AAPL?

Apple Inc. (AAPL) is growing the fastest with 6.4% revenue growth. Virax Biolabs Group Limited has the slowest growth at -96.0%. Higher growth often justifies higher valuations.

Which has the best profit margins: VRAX or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Virax Biolabs Group Limited has the lowest at -957.4%. Higher margins indicate pricing power and efficiency.

Which is the largest company: VRAX or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. Virax Biolabs Group Limited is the smallest at $0.0B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: VRAX or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Virax Biolabs Group Limited has the lowest at -1.1%. Higher ROE indicates efficient use of capital.